Navigation Links
Benitec MOU With CalbaTech, Inc.
Date:8/19/2007

al companies and to academic institutions. CalbaTech's wholly owned subsidiary LifeStem has developed a unique process to harvest stem cells in micro quantities to be cryopreserved for future transplantation into a client for medical purposes. The collection of stem cells from two different tissue sources increases the potential for treatment of more diseases. CalbaTech's new wholly-owned subsidiary, TherapyStem, Inc., with its patent pending collection service, will provide collection and processing stem cell services for individuals with infectious diseases, for possible use in potential therapeutic applications, like those created by the City of Hope, under a license agreement with Benitec, an Australian corporation.

Gene silencing

Gene silencing is about controlling the flow of genetic information. Our genome operates by sending instructions for the manufacture of proteins from DNA in the nucleus of the cell to the protein synthesizing machinery. These instructions are conveyed by messenger RNA (mRNA). In 1998 it was discovered that a certain mechanism can degrade mRNA from a specific gene. This mechanism is RNA interference. It is activated when RNA molecules occur as double-stranded pairs in the cell. Double-stranded RNA activates biochemical machinery which degrades those mRNA molecules that carry a genetic code identical to that of the double-stranded RNA. When such mRNA molecules disappear, the corresponding gene is silenced.

RNA interference is of great importance for the regulation of gene expression and can be used against viral infections. RNA interference is already being widely used in basic science as a method to study the function of genes and Benitec believes it will lead to novel therapies.

Forward-looking Statements

This press release contains forward-looking statements that reflect the Companies' current expectations regarding future events. Forward-looking statements involve risks and uncertainties. Actual events c
'/>"/>

SOURCE Benitec Limited; CalbaTech, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4

Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Patent Expiries of Blockbuster Antibiotics Will Fuel a Decline of More Than 15 Percent in the Community-Acquired Pneumonia Drug Market 2$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 2$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 3$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 4$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 5$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 6Roche Diagnostics Opens State-of-the-Art Training Center in California 2FQHC Stigler Health and Wellness Center Chooses Sage Intergy CHC to Meet Unique Reporting Requirements 59804 1FQHC Stigler Health and Wellness Center Chooses Sage Intergy CHC to Meet Unique Reporting Requirements 59804 2Aegis Health Group Tapped by White Memorial Medical Center in Los Angeles to Help Strengthen Local Physician Relationships 59800 1Aegis Health Group Tapped by White Memorial Medical Center in Los Angeles to Help Strengthen Local Physician Relationships 59800 2Colorado Center for Reproductive Medicine Improves Pregnancy and Implantation Rates Using Comprehensive Chromosomal Screening of IVF Embryos 14540 1Colorado Center for Reproductive Medicine Improves Pregnancy and Implantation Rates Using Comprehensive Chromosomal Screening of IVF Embryos 14540 2Colorado Center for Reproductive Medicine Improves Pregnancy and Implantation Rates Using Comprehensive Chromosomal Screening of IVF Embryos 14540 3